Call for Proposals

CMIEDF offers financial support to innovators, developers, and academic institutions in Canada, specifically in the field of radiopharmaceutical and medical isotope technologies. This funding is designed to expedite the progress of early-stage programs, thereby creating a continuous pipeline for development and eventual commercialization.

CMIEDF has $5 million to dedicate to advancing medical isotope technologies within Canada. Individual project support will range from $200-500k. CMIEDF will provide a reimbursement up to 50% of eligible project costs when at least 50% of the project is funded by non-federal government sources. Additionally, each project must actively involve at least one small to medium enterprise (SME).

For radiopharmaceutical programs, we are seeking programs spanning from the pre-clinical proof of concept phase to early clinical trials and progressing into the pre-commercialization stage.


Our second call for proposals is now open!

Submission Deadline: August 20, 2024 at 11:59pm Pacific Standard Time (PST)

The first round of applications is a brief, non-confidential PowerPoint presentation.  Questions and topics have been included in the template slide deck for applicants to complete (Download CMIEDF Application below).  Applications are to be submitted in PowerPoint format, with a maximum of 10 slides.

When completing the application, be aware of the evaluation criteria which reviewers will use to score your application (Download Guideline for Applicants documents below).

Top ranking applicants will be contacted on September 20, 2024, where applicants will be asked to submit a written report and deliver a 30-minute confidential pitch presentation to the Eligible Project Selection Committee which will describe in greater detail the project.

Download these key documents:

Key Dates:

  • Call for Proposals Opens: June 27, 2024
  • Call for Proposals Closes: August 20, 2024
  • Inform applicants moving to second stage: September 20, 2024
  • Deadline to submit written report and confidential pitch slides: November 8, 2024
  • Pitch Presentation: November 18-22, 2024
  • Inform selected applicants to receive funding: December 16, 2024
  • Funding Starts: January 1, 2025

If there are any questions regarding the CMIEDF application process, please contact us at


This application is open to Canadian small to medium enterprises (SMEs), academic institutions, not-for-profit organizations, multi-national enterprises (MNEs), and research institutes. Each project must actively involve at least one SME.

The CMIE Development Fund aims to foster the creation of new companies and expedite the commercialization of Canadian assets within the medical isotope industry. In alignment with this objective, we will prioritize applications from independent companies that are not subsidiaries of larger corporations.

This funding cycle will support radiopharmaceutical and medical isotope technology research programs. We are seeking programs with high impact collaborations that foster business and technology development with enhanced emphasis on commercialization. Eligible programs can be at a Technology Readiness Level (TRL) of 1-9.

The CMIE is particularly interested in innovative medical isotope technologies that aid in diagnosing and treating rare or difficult-to-treat diseases.

Additionally, the CMIE Development Fund is not currently accepting proposals for investigational studies or case reports.

Program funding can be requested between $200,000 and $500,000. CMIEDF will provide a reimbursement up to 50% of eligible project costs when at least 25% of the total project cost is funded by non-government sources.

An Ultimate Recipient Agreement (URA) is a formal contract between the two Lead Recipients of the CMIE (Centre for Probe Development and Commercialization and TRIUMF Innovations) and the party receiving the funding (the Ultimate Recipient). This agreement details the obligations of both the Lead Recipients and the Ultimate Recipient regarding the eligible project and project funding, claims and payments, reporting, monitoring, audit and evaluation, representation, warranties, and covenants, intellectual property, confidentiality, publicity, indemnification and limitation of liability, default and remedies, term, termination, survival, notices, and general provisions.

The terms outlined in the URA are non-negotiable. They should be reviewed carefully before applying for funding.

The current Call for Proposals will open June 27, 2024. This round of applications will close on August 20, 2024 at 11:59pm Pacific Standard Time (PST). 

Refundable claims will be accepted for eligible project work that began no earlier than January 1, 2025, and ended no later than January 31 2026. Projects should be less than 12 months in length. 

All applications must be sent to

Join our community, it's free!

Receive the latest news and updates on funding calls and networking events.